PT  - JOURNAL ARTICLE
AU  - Teng, Michele W.L.
AU  - Khanna, Rajiv
AU  - Smyth, Mark J.
TI  - Checkpoint Immunotherapy: Picking a Winner
AID  - 10.1158/2159-8290.CD-16-0694
DP  - 2016 Aug 01
TA  - Cancer Discovery
PG  - 818--820
VI  - 6
IP  - 8
4099  - http://cancerdiscovery.aacrjournals.org/content/6/8/818.short
4100  - http://cancerdiscovery.aacrjournals.org/content/6/8/818.full
SO  - Cancer Discov2016 Aug 01; 6
AB  - Summary: Robust biomarkers of response that predict which patients will or will not respond to immune checkpoint blockade need to be identified. New data suggest that the presence of an adaptive immune signature in the tumor biopsies of patients with melanoma early on therapy compared to pretreatment can identify responders from nonresponders. Cancer Discov; 6(8); 818–20. ©2016 AACR.See related article by Chen et al., p. 827.